Catalyst Wire Dossier Catalyst Wire Dossier

VEOPOZ

POZELIMAB · Regeneron Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VEOPOZ, covering 2023-08-18 to 2023-08-18. Get the full timeline:

Most recent: FDA Approved: VEOPOZ — Original Application (Regeneron Pharmaceuticals, Inc.)

See pricing